Can Right Ventricular Endomyocardial Biopsy Predict Left Ventricular Fibrosis Beforehand in Dilated Cardiomyopathy?
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14642 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Kisaki Amemiya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, Culture, Sport, Science, and Technology, Japan.
Abstract (Originalsprache)
Aims
Myocardial fibrosis of the left ventricle (LV) is a prognostic factor in dilated cardiomyopathy (DCM). This study aims to evaluate whether fibrosis of right ventricular (RV) endomyocardial biopsy (EMB) can predict the degree of LV fibrosis beforehand in DCM. Methods and results Fibrosis extent in 70 RV-EMB specimens of DCM diagnosis was compared with that in the whole cross-sectional LV of excised hearts in the same patients (52 explanted hearts for transplant and 18 autopsied hearts). The median interval between biopsy and excision was 4.1 (0.13–19.3) years. The fibrosis area ratio of the EMBs and excised hearts were evaluated via image analysis. The distribution of cardiovascular magnetic resonance–late gadolinium enhancement (LGE) in the intraventricular septum was classified into four quartile categories. The fibrosis area ratio in RV-EMB correlated significantly with that in the short-axis cut of the LV of excised hearts (r = 0.82, P < 0.0001) and with a diffuse pattern of LGE (r = 0.71, P = 0.003). In a multivariate model, after adjusting for the interval between biopsy performance and heart excision, the fibrosis area ratio in RV-EMB was associated with that in LV-excised heart (regression coefficient, 0.82; 95% confidence interval, 0.68–0.95; P < 0.0001).
Conclusions
The fibrosis observed in RV-EMB positively correlated with the extent of fibrosis in the LV of excised hearts in patients with DCM. The study findings may help predict LV fibrosis, considered a prognostic factor of DCM through relatively accessible biopsy techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan.
- Department of Legal Medicine, Showa University School of Medicine, Tokyo, Japan.
- Division of Pathology, Hokusetsu General Hospital, Osaka, Japan.
- Department of Radiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
- Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
- Senri Kinran University, Osaka, Japan.
ORCID-Profile: Kisaki Amemiya
Förderung
- Ministry of Education, Culture, Sport, Science, and Technology, Japan
Zitieren
APA
Amemiya, K., Matsuyama, T. A., Ishibashi-Ueda, H., Morita, Y., Matsumoto, M., Ohta-Ogo, K., Ikeda, Y., Tsukamoto, Y., Fukushima, N., Fukushima, S., Fujita, T., & Hatakeyama, K. (2024). Can Right Ventricular Endomyocardial Biopsy Predict Left Ventricular Fibrosis Beforehand in Dilated Cardiomyopathy?. ESC Heart Failure. https://doi.org/10.1002/ehf2.14642
Vancouver
Amemiya K, Matsuyama TA, Ishibashi-Ueda H, Morita Y, Matsumoto M, Ohta-Ogo K, et al. Can Right Ventricular Endomyocardial Biopsy Predict Left Ventricular Fibrosis Beforehand in Dilated Cardiomyopathy?. ESC Heart Failure. 2024. doi:10.1002/ehf2.14642
BibTeX
@article{Amemiya2024,
author = {Amemiya, Kisaki and Matsuyama, Taka-Aki and Ishibashi-Ueda, Hatsue and Morita, Yoshiaki and Matsumoto, Manabu and Ohta-Ogo, Keiko and Ikeda, Yoshihiko and Tsukamoto, Yasumasa and Fukushima, Norihide and Fukushima, Satsuki and Fujita, Tomoyuki and Hatakeyama, Kinta},
title = {Can Right Ventricular Endomyocardial Biopsy Predict Left Ventricular Fibrosis Beforehand in Dilated Cardiomyopathy?},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14642}
}
EUVIMED